Breast |
Microarray profiles of 295 human breast tumors |
High STIM1, low STIM2 |
Associated with poor prognosis |
45 |
Breast |
MDA-MB-231, MC-7, T47D, BT-483 |
Elevated Orai1 |
Remodeling of Ca2+ influx associated with invasive stimuli |
45 |
Breast |
MCF-7 cells and cancerous breast tissue samples |
High Orai3 expression |
Promotes cell proliferation, cell cycle progression and apoptosis resistance |
49 |
Cervical cancer |
primary cervical cancer tissues |
Overexpression of STIM1 |
Reduces five-year survival rate; Promotes tumor cell growth, cell cycle progression, migration, invasion and angiogenesis |
50 |
Ovarian cancer |
A2780cis (cisplatin resistant) cells |
High Orai1 and STIM1 expression |
Contributes to therapy resistance |
52 |
Renal Cancer |
ccRCC tissues |
High expression of Orai1 |
Promotes cell proliferation and migration |
53 |
Colorectal cancer |
Patient tumor tissue specimen |
STIM1 overexpression |
Increases tumor size, invasion and migration |
54 |
Colorectal cancer |
SW620 and LOVO cells |
STIM1 overexpression |
Promotes metastasis and EMT |
55 |
Colorectal cancer |
Tissue microarray of 90 CRC patients |
STIM1 overexpression |
Indicative of poor prognosis |
55 |
Gastric cancer |
Tumor tissues from 327 GC patients |
High Orai and STIM1 expression |
Correlates with frequent recurrence and high mortality rate |
57 |
Liver cancer |
Hepatoma tissues and HCC cell lines |
Higher expression of STIM1 |
Correlates with high metastatic potential in patients and higher migration ability in cell lines |
58 |
Liver cancer |
Hepatocarcinoma tissues |
Elevated Orai1 expression |
Serves as predictor of 5-FU sensitivity |
59 |
Pancreatic cancer |
Panc-1 cells |
High expression of Orai1 and STIM1 |
Contributes to apoptosis resistance |
60 |
Esophageal cancer |
Tumor tissues from ESCC patients |
Elevated expression of Orai1 |
Linked to poor overall and recurrence-free survival |
61 |
Lung cancer |
NSCLC tumor tissues |
Higher STIM1 expression |
Promotes tumorigenesis |
62 |
Lung cancer |
Tumor samples from 60 lung adenocarcinoma patients |
Orai3 overexpression |
Correlates with high tumor grade |
63 |
Glioblastoma |
U251 cells |
Higher expression of STIM1 |
Promotes cell proliferation and invasion |
65 |
Glioblastoma |
Primary human cell lines established from glioblastoma surgical samples |
Increased Orai1 levels |
Promotes cell invasion |
66 |
Glioblastoma |
Tumor tissues from 61 glioma patients |
Elevated Orai expression |
Correlates with high tumor grade |
67 |
Glioblastoma |
Human glioma cell lines U251, SNB19, U87, and LN229 |
Elevated Orai expression |
Promotes cell migration and invasion |
67 |
Leukemia |
HL60 cells |
High expression of Orai2 |
Promotes cell migration |
68 |
Multiple myeloma |
Tumor tissues from 60 Multiple Myeloma patients |
Increased expression of STIM1 and Orai1 |
Associated with poor prognosis |
69 |
Multiple myeloma |
KM3 and U266 cells |
Increased expression of STIM1 and Orai1 |
Promotes cell growth and apoptosis resistance |
69 |